Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) * Biomerica, Inc. (NASDAQ: BMRA)( announced comm
Acer Therapeutics (ACER) Receives a Hold from Needham
09:38am, Thursday, 19'th Mar 2020
Needham analyst Serge Belanger maintained a Hold rating on Acer Therapeutics (ACER) today. The company's shares closed last Monday at $2.02, close to its
Acer Therapeutics (ACER) Receives a Hold from Needham
09:38am, Thursday, 19'th Mar 2020
Needham analyst
Serge Belanger
maintained a
Hold
rating on Acer Therapeutics (
ACER
–
Research Report
) today. The company’s shares closed last Monday at $2.02, close to its 52-week low of $1.87.
Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 1-Year Low on Insider Selling
07:14am, Thursday, 19'th Mar 2020
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)’s stock price hit a new 52-week low during mid-day trading on Wednesday following insider selling activity. The stock traded as low as $12.90 and last tra
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) CFO Sells $65,531.94 in Stock
08:48am, Wednesday, 18'th Mar 2020
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) CFO William J. Peters sold 4,701 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average p
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI) and Moderna (MRNA)
08:02pm, Monday, 16'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Trevi Therapeutics (TRVI) and Moderna (MRNA) with bullish
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (NASDAQ: TRVI) and Moderna (NASDAQ: MRNA)
08:02pm, Monday, 16'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Trevi Therapeutics
Head to Head Review: Synlogic (NASDAQ:SYBX) and Amphastar Pharmaceuticals (NASDAQ:AMPH)
05:46am, Monday, 16'th Mar 2020
Synlogic (NASDAQ:SYBX) and Amphastar Pharmaceuticals (NASDAQ:AMPH) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of
Zacks Investment Research Upgrades Amphastar Pharmaceuticals (NASDAQ:AMPH) to "Buy"
07:10am, Sunday, 15'th Mar 2020
Amphastar Pharmaceuticals (NASDAQ:AMPH) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday, Zacks.c
Needham Sticks to Its Hold Rating for Amphastar Pharmaceuticals (AMPH)
09:36pm, Friday, 13'th Mar 2020
Needham analyst Serge Belanger maintained a Hold rating on Amphastar Pharmaceuticals (AMPH) today. The company's shares closed last Monday at $14.19,
Needham Sticks to Its Hold Rating for Amphastar Pharmaceuticals (AMPH)
09:36pm, Friday, 13'th Mar 2020
Needham analyst
Serge Belanger
maintained a
Hold
rating on Amphastar Pharmaceuticals (
AMPH
–
Research Report
) today. The company’s shares closed last Monday at $14.19, close to its 52-week low o
Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL) and Homology Medicines (FIXX)
01:53pm, Friday, 13'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Collegium Pharmaceutical (COLL) and Homology Medicines
Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (NASDAQ: COLL) and Homology Medicines (NASDAQ: FIXX)
01:53pm, Friday, 13'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Collegium Pharmaceutical
